# Glaucoma Adherence Study, Spain

> **NCT00680329** · — · COMPLETED · sponsor: **Alcon Research** · enrollment: 55 (actual)

## Conditions studied

- Ocular Hypertension
- Primary Open Angle Glaucoma

## Interventions

- **DRUG:** Travoprost 0.004%/timolol 0.05% fixed combination eye drops (DuoTrav)
- **DEVICE:** Travalert Dosing Aid

## Key facts

- **NCT ID:** NCT00680329
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2012-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00680329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00680329, "Glaucoma Adherence Study, Spain". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00680329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*